Canna~Fangled Abstracts Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders Review Trends Pharmacol Sci. 2025 Jan 20:S0165-6147(24)00271-2. doi: 10.1016/j.tips.2024.12.005. Online ahead of print. Olivier J…Freedom WaresJanuary 20, 2025
Canna~Fangled Abstracts Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview Review Top Curr Chem (Cham). 2024 Jun 3;382(2):20. doi: 10.1007/s41061-024-00465-w. Iqra Kalsoom 1, Kiran Shehzadi 1, Han-Sheng Li 1, Hong-Liang Wen 1, Ming-Jia…Freedom WaresJune 3, 2024
Canna~Fangled Abstracts Cannabidiol improves haloperidol-induced motor dysfunction in zebrafish: a comparative study with a dopamine activating drug Journal List J Cannabis Res v.5; 2023 PMC9985202 J Cannabis Res. 2023; 5: 6. Published online…Freedom WaresMarch 4, 2023
Canna~Fangled Abstracts The role of cannabinoids in neurodevelopmental disorders of children and adolescents Review Rev Neurol. 2022 Oct 1;75(7):189-197. doi: 10.33588/rn.7507.2022123. F Dias-de Freitas 1, S Pimenta 2, S Soares 3, D Gonzaga 3, I Vaz-Matos 3, C…Freedom WaresOctober 1, 2022
Canna~Fangled Abstracts Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment. Biochem Pharmacol. 2020 Apr 28:114004. doi: 10.1016/j.bcp.2020.114004. Stark T1, Di Bartolomeo M2, Di Marco R3,…Freedom WaresApril 28, 2020
Canna~Fangled Abstracts Cannabidiol Attenuates Behavioral Changes in a Rodent Model of Schizophrenia Through 5-HT1A, but Not CB1 and CB2 Receptors Pharmacol Res, 104749 2020 Mar 6 Naielly Rodrigues da Silva 1, Felipe Villela Gomes 2, Andreza Buzolin Sonego 2, Nicole Rodrigues…Freedom WaresMarch 6, 2020
Canna~Fangled Abstracts Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis. Transl Psychiatry. 2019 Aug 22;9(1):203. doi: 10.1038/s41398-019-0534-2. Wilson R1, Bossong MG1,2, Appiah-Kusi E1, Petros N1,…Freedom WaresAugust 22, 2019
Canna~Fangled Abstracts Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders? Front Pharmacol. 2018 May 11;9:482. doi: 10.3389/fphar.2018.00482. eCollection 2018. Peres FF1,2, Lima AC1, Hallak JEC2,3,…Freedom WaresMay 11, 2018
For Your Consideration... Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 12. pii: S0278-5846(17)30262-2. doi: 10.1016/j.pnpbp.2017.06.005. Delis F1, Rosko L2,…Freedom WaresJune 12, 2017
Canna~Fangled Abstracts Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose. 2016 Oct 18;6(10):e920. doi: 10.1038/tp.2016.195. Seeman P1,2. Author information Abstract Although all current antipsychotics act…Freedom WaresOctober 18, 2016